173 related articles for article (PubMed ID: 9221054)
1. [Non-insulin-dependent diabetes: from physiopathology to treatment].
Scheen AJ; Lefebvre PJ
Bull Mem Acad R Med Belg; 1996; 151(7-9):395-402; discussion 402-5. PubMed ID: 9221054
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of type 2 diabetes and its relationship to new therapeutic approaches.
Bell D
Diabetes Educ; 2000; 26 Suppl():4-7. PubMed ID: 11912815
[No Abstract] [Full Text] [Related]
3. Focus on insulin resistance in type 2 diabetes: therapeutic implications.
Reusch JE
Diabetes Educ; 1998; 24(2):188-93. PubMed ID: 9555358
[TBL] [Abstract][Full Text] [Related]
4. [Etiopathogenesis, physiopathology and general principles of therapy of type II diabetes].
Scheen A; Lefèbvre PJ
Rev Med Liege; 1988 Apr; 43(7):205-11. PubMed ID: 3287543
[No Abstract] [Full Text] [Related]
5. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
6. [Insulin secretion and repaglinide].
Owens D
Diabetes Metab; 1999 Dec; 25 Suppl 7():17-9. PubMed ID: 10746006
[TBL] [Abstract][Full Text] [Related]
7. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
van Raalte DH; Verchere CB
Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
Chan JL; Abrahamson MJ
Mayo Clin Proc; 2003 Apr; 78(4):459-67. PubMed ID: 12683698
[TBL] [Abstract][Full Text] [Related]
9. [Type 2 diabetes mellitus].
Kashiwagi A
Nihon Rinsho; 2006 Sep; Suppl 3():42-8. PubMed ID: 17022497
[No Abstract] [Full Text] [Related]
10. [Etiology of and therapy for type-2 diabetes mellitus].
Kazuga M
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):527-31. PubMed ID: 15052815
[No Abstract] [Full Text] [Related]
11. Non-insulin-dependent diabetes mellitus: a clinical strategy.
Skyler JS
Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
[TBL] [Abstract][Full Text] [Related]
12. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
13. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Szoke E; Gerich JE
Compr Ther; 2005; 31(2):106-12. PubMed ID: 15901939
[TBL] [Abstract][Full Text] [Related]
14. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.
Standl E; Füchtenbusch M
Diabetologia; 2003 Mar; 46 Suppl 1():M30-6. PubMed ID: 12652356
[TBL] [Abstract][Full Text] [Related]
15. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
Brown A; Guess N; Dornhorst A; Taheri S; Frost G
Diabetes Obes Metab; 2017 Dec; 19(12):1655-1668. PubMed ID: 28509408
[TBL] [Abstract][Full Text] [Related]
16. Matching treatment to pathophysiology in type 2 diabetes.
Gerich JE
Clin Ther; 2001 May; 23(5):646-59; discussion 645. PubMed ID: 11394726
[TBL] [Abstract][Full Text] [Related]
17. Practical guidelines on the use of insulin lispro in elderly diabetic patients.
Benbarka MM; Prescott PT; Aoki TT
Drugs Aging; 1998 Feb; 12(2):103-13. PubMed ID: 9509289
[TBL] [Abstract][Full Text] [Related]
18. Therapy for type 2 diabetes mellitus.
Elson DF; Meredith M
WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
[TBL] [Abstract][Full Text] [Related]
19. [Diabetes mellitus].
Bosi E
G Ital Nefrol; 2003; 20 Suppl 25():S3-6. PubMed ID: 14523905
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of type 2 diabetes mellitus.
DeFronzo RA
Med Clin North Am; 2004 Jul; 88(4):787-835, ix. PubMed ID: 15308380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
